Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13G/A

Passive or exempt beneficial ownership filing.

Ownership

20%

Beneficial ownership of this reported class.

Shares

187,083,713 shares

Shares beneficially owned as disclosed.

Event date

31 Mar 2026

Date tied to the ownership event or amendment.

Accepted by SEC

06 May 2026

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
MDLN
Shares outstanding
944,867,237 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13G/A
Accepted by SEC
06 May 2026, 21:07:24 UTC
Event date
31 Mar 2026
Prior SEC filing
13 Feb 2026
Source filing
View source filing

Key filing fact

Hellman & Friedman Capital Partners X (Parallel), L.P. disclosed 20% ownership in Medline Inc. Class A common stock, par value $0.0001 per share (MDLN) on 31 Mar 2026.

Key facts

  • Hellman & Friedman Capital Partners X (Parallel), L.P. filed SCHEDULE 13G/A for Medline Inc. Class A common stock, par value $0.0001 per share (MDLN).
  • Disclosed ownership: 20%.
  • Date of event: 31 Mar 2026.

Change

  • Previous schedule filing date: 13 Feb 2026.
  • Current filing was accepted on 06 May 2026, 21:07.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (9)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Hellman & Friedman Capital Partners X (Parallel), L.P. 7.9% 74,496,172 74,496,172 /s/ Jacob Best Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
HFCP X (Parallel - A), L.P. 0.8% 7,781,788 7,781,788 /s/ Jacob Best Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
Mend Partners II, L.P. 0.4% 4,176,227 4,176,227 /s/ Jacob Best Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
Mend Investment Holdings I, L.P. 11% 100,629,526 100,629,526 /s/ Jacob Best Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
Hellman & Friedman Investors X, L.P. 20% 187,083,713 187,083,713 /s/ Jacob Best Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
Mend Partners GP, LLC 0.4% 4,176,227 4,176,227 /s/ Jacob Best Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
Mend Investment Holdings GP, LLC 11% 100,629,526 100,629,526 /s/ Jacob Best Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
Hellman & Friedman Capital Partners X, L.P. 11% 100,629,526 100,629,526 /s/ Jacob Best Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
H&F Corporate Investors X, Ltd. 20% 187,083,713 187,083,713 /s/ Jacob Best Jacob Best, Vice President of H&F Corporate Investors X, Ltd., See Exhibit 99.1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .